Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 543517, 8 pages
http://dx.doi.org/10.1155/2015/543517
Research Article

Traditional Chinese Medicine Decreases the Stroke Risk of Systemic Corticosteroid Treatment in Dermatitis: A Nationwide Population-Based Study

1Institute of Chinese Medicine, School of Chinese Medicine, Graduate Institute of Integrated Medicine, School of Post-Baccalaureate Chinese Medicine, Research Center for Chinese Medicine & Acupuncture, Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung 40402, Taiwan
2Departments of Dermatology, Medical Research, Obstetrics and Gynecology, and Urology, Management Office for Health Data, China Medical University Hospital, Taichung 40447, Taiwan
3Department of Applied Cosmetology, Master Program of Cosmetic Science, and Department of Cultural and Creative Industries, Hungkuang University, Taichung 43302, Taiwan
4Center for General Education, Feng Chia University, Taichung 40724, Taiwan
5Department of Dermatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan
6Department of Psychology, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan

Received 4 March 2015; Accepted 15 June 2015

Academic Editor: Cheryl Hawk

Copyright © 2015 Kao-Sung Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Kim, D. H. Kim, M. S. Lee, J. I. Kim, L. S. Wieland, and B. C. Shin, “Randomized controlled trials on complementary and traditional medicine in the korean literature,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 194047, 10 pages, 2014. View at Publisher · View at Google Scholar
  2. C. Wu, C. Wang, M. Tsai, W. Huang, and J. Kennedy, “Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveys,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 872320, 7 pages, 2014. View at Publisher · View at Google Scholar
  3. M. Steinhoff, A. Steinhoff, B. Homey, T. A. Luger, and S. W. Schneider, “Role of vasculature in atopic dermatitis,” The Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 190–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Wang, H. Gao, C. M. Loyd et al., “Chronic skin-specific inflammation promotes vascular inflammation and thrombosis,” Journal of Investigative Dermatology, vol. 132, no. 8, pp. 2067–2075, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Shenoy, K. A. Shenoy, and U. P. Ratnakar, “The perceptual preferences in learning among dental students in clinical subjects,” Journal of Clinical and Diagnostic Research, vol. 7, no. 8, pp. 1683–1685, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. V. Elkind, “Inflammatory markers and stroke,” Current Cardiology Reports, vol. 11, no. 1, pp. 12–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. L. N. Husemoen, T. Skaaby, T. Jørgensen et al., “No association between loss-of-function mutations in filaggrin and diabetes, cardiovascular disease, and all-cause mortality,” PLoS ONE, vol. 8, no. 12, Article ID e84293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Y.-F. Su, T.-J. Chen, C.-M. Yeh et al., “Atopic dermatitis and risk of ischemic stroke: a nationwide population-based study,” Annals of Medicine, vol. 46, no. 2, pp. 84–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Formiga, J. F. Meco, X. Pinto, J. Jacob, I. Moga, and R. Pujol, “Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients,” Lupus, vol. 10, no. 5, pp. 359–363, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. B. F. A. Freire, R. C. da Silva, A. T. Fabro, and D. C. dos Santos, “Is systemic lupus erithematosus a new risk factor for atherosclerosis?” Arquivos Brasileiros de Cardiologia, vol. 87, no. 3, pp. 300–306, 2006. View at Google Scholar · View at Scopus
  11. K.-L. E. Hon, T. F. Leung, H. C. Yau, and T. Chan, “Paradoxical use of oral and topical steroids in steroid-phobic patients resorting to traditional Chinese medicines,” World Journal of Pediatrics, vol. 8, no. 3, pp. 263–267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. I. Silverberg, M. Lee-Wong, and N. B. Silverberg, “Complementary and alternative medicines and childhood eczema: a US population-based study,” Dermatitis, vol. 25, no. 5, pp. 246–254, 2014. View at Publisher · View at Google Scholar
  13. K.-S. Tsai, T.-C. Lin, M.-T. Wu et al., “Irritant contact dermatitis risk of common topical traditional chinese medicines used for skin-lightening: a pilot clinical trial with 30 volunteers,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 609064, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. P. E. Harris, K. L. Cooper, C. Relton, and K. J. Thomas, “Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update,” International Journal of Clinical Practice, vol. 66, no. 10, pp. 924–939, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Y. Chen, Y. C. Chang, C. C. Lin, F. C. Sung, and W. C. Chen, “Obstructive sleep apnea patients having surgery are less associated with glaucoma,” Journal of Ophthalmology, vol. 2014, Article ID 838912, 6 pages, 2014. View at Publisher · View at Google Scholar
  16. H.-Y. Chen, Y.-C. Chang, I.-J. Wang, and W.-C. Chen, “Comparison of glaucoma diagnoses using Stratus and Cirrus optical coherence tomography in different glaucoma types in a Chinese population,” Journal of Glaucoma, vol. 22, no. 8, pp. 638–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Wacholder, J. K. McLaughlin, D. T. Silverman, and J. S. Mandel, “Selection of controls in case-control studies. I. Principles,” American Journal of Epidemiology, vol. 135, no. 9, pp. 1019–1028, 1992. View at Google Scholar · View at Scopus
  18. T. F. Leung, K. Y. Wong, C. K. Wong et al., “In vitro and clinical immunomodulatory effects of a novel Pentaherbs concoction for atopic dermatitis,” British Journal of Dermatology, vol. 158, no. 6, pp. 1216–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Zonana-Nacach, S. G. Barr, L. S. Magder, and M. Petri, “Damage in systemic lupus erythematosus and its association with corticosteroids,” Arthritis and Rheumatism, vol. 43, no. 8, pp. 1801–1808, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Wei, T. M. MacDonald, and B. R. Walker, “Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease,” Annals of Internal Medicine, vol. 141, no. 10, pp. 764–770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. C. F. Christiansen, S. Christensen, F. Mehnert, S. R. Cummings, R. D. Chapurlat, and H. T. Sørensen, “Glucocorticoid use and risk of atrial fibrillation or flutter: A population-based, case-control study,” Archives of Internal Medicine, vol. 169, no. 18, pp. 1677–1683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. T. Lear, R. H. Neary, P. Jones, D. A. Fitzgerald, and J. S. C. English, “Risk factors for ischaemic heart disease in patients with dermatitis herpetiformis,” Journal of the Royal Society of Medicine, vol. 90, no. 5, pp. 247–249, 1997. View at Google Scholar · View at Scopus
  23. I. N. Bruce, “‘Not only...but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus,” Rheumatology, vol. 44, no. 12, pp. 1492–1502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. J. Chen, C. Y. Wu, M. W. Lin et al., “Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study,” British Journal of Dermatology, vol. 165, no. 3, pp. 593–599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Cahyanur, D. Oktavia, and S. Koesno, “DRESS and Ischemic Stroke,” Acta Medica Indonesiana, vol. 44, no. 3, pp. 239–242, 2012. View at Google Scholar · View at Scopus
  26. C.-H. Chiang, C.-C. Huang, W.-L. Chan et al., “Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study,” Journal of Dermatology, vol. 39, no. 3, pp. 279–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Sivaranjani, S. Venkata Rao, and G. Rajeev, “Role of reactive oxygen species and antioxidants in atopic dermatitis,” Journal of Clinical and Diagnostic Research, vol. 7, no. 12, pp. 2683–2685, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. C. Pitchford, H. Yano, R. Lever et al., “Platelets are essential for leukocyte recruitment in allergic inflammation,” Journal of Allergy and Clinical Immunology, vol. 112, no. 1, pp. 109–118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Gawaz, H. Langer, and A. E. May, “Platelets in inflammation and atherogenesis,” Journal of Clinical Investigation, vol. 115, no. 12, pp. 3378–3384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Tamagawa-Mineoka, N. Katoh, E. Ueda, K. Masuda, and S. Kishimoto, “Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis,” Clinical Immunology, vol. 131, no. 3, pp. 495–500, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Nastalek, A. Wojas-Pelc, and A. Undas, “Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy,” Journal of Thrombosis and Thrombolysis, vol. 30, no. 2, pp. 121–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Sun, G. K. Sukhova, P. J. Wolters et al., “Mast cells promote atherosclerosis by releasing proinflammatory cytokines,” Nature Medicine, vol. 13, no. 6, pp. 719–724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Ihara, H. Urata, A. Kinoshita et al., “Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta,” Hypertension, vol. 33, no. 6, pp. 1399–1405, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Jeziorska, C. Mccollum, and D. E. Woolley, “Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries,” Journal of Pathology, vol. 182, no. 1, pp. 115–122, 1997. View at Google Scholar · View at Scopus
  35. J.-G. Wang, S. A. Mahmud, J. A. Thompson, J.-G. Geng, N. S. Key, and A. Slungaard, “The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states,” Blood, vol. 107, no. 2, pp. 558–565, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. P. W. Kaplan, “Central nervous system problems with eosinophilia,” Archives of Neurology, vol. 68, no. 12, pp. 1613–1614, 2011. View at Google Scholar · View at Scopus
  37. L. Y. Chung, “Antioxidant profiles of a prepared extract of Chinese herbs for the treatment of atopic eczema,” Phytotherapy Research, vol. 22, no. 4, pp. 493–499, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. B. C. L. Chan, K. L. E. Hon, P. C. Leung et al., “Traditional Chinese medicine for atopic eczema: pentaHerbs formula suppresses inflammatory mediators release from mast cells,” Journal of Ethnopharmacology, vol. 120, no. 1, pp. 85–91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. H. T. Sørensen, S. Sabroe, and J. Olsen, “A framework for evaluation of secondary data sources for epidemiological research,” International Journal of Epidemiology, vol. 25, no. 2, pp. 435–442, 1996. View at Publisher · View at Google Scholar · View at Scopus